What question did this study set out to answer?

This research aims to investigate the levels of asprosin and subfatin in non-obese women with PCOS.

February 22, 2026Endokrynologia Polska0 citationsOpen Access

Asprosin, but not subfatin, associated with non-obese polycystic ovary syndrome

RBReha Baran STSuzan Tabur STSeyithan Taysı

Key Points

This research aims to investigate the levels of asprosin and subfatin in non-obese women with PCOS.
Analyzed blood samples from non-obese women diagnosed with PCOS.
Measured levels of asprosin and subfatin to compare with control group.
Assessed the relationship between asprosin levels and insulin resistance.
Asprosin levels were significantly higher in women with PCOS compared to controls.
Subfatin levels showed no significant differences between groups.
Elevated asprosin may act as a marker for PCOS independent of insulin resistance.

Abstract

Asprosin, but not subfatin, was significantly elevated in non-obese women with PCOS. It may serve as a marker of PCOS independent of insulin resistance in normal-weight women.

问 AI

Bookmark

View Full Paper